<!DOCTYPE html>
<html lang='en'>
  <head>
    <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-PK63DK');</script>
    <meta content='text/html; charset=UTF-8' http-equiv='Content-Type'>
    <meta charset='utf-8'>
    <meta content='width=device-width, initial-scale=1, shrink-to-fit=no' name='viewport'>
    <link crossorigin='anonymous' href='https://stackpath.bootstrapcdn.com/bootstrap/4.1.1/css/bootstrap.min.css' integrity='sha384-WskhaSGFgHYWDcbwN70/dfYBj47jz9qbsMId/iRN3ewGhXQFZCSftd1LZCfmhktB' rel='stylesheet'>
    <link href='/styles.css' rel='stylesheet'>
    <title>NMT Pharmaceuticals Singapore Announces Signing of Letter...</title>
    <script async='async' src='https://www.googletagservices.com/tag/js/gpt.js'></script><script>var googletag=googletag ||{}; googletag.cmd=googletag.cmd || [];</script><script>googletag.cmd.push(function(){googletag.defineSlot('\/1010898\/sgforums_interstitial', [ 1.0 , 1.0], 'div-gpt-ad-1528181032761-0').setTargeting('forum', ['3513']).setTargeting('topic', ['489756']).addService(googletag.pubads()); googletag.defineSlot('\/1010898\/sgforums_leaderboard', [[ 728.0 , 90.0], [ 970.0 , 250.0]], 'div-gpt-ad-1528181032761-1').setTargeting('forum', ['3513']).setTargeting('topic', ['489756']).addService(googletag.pubads()); googletag.defineSlot('\/1010898\/sgforums_mpu', [ 300.0 , 250.0], 'div-gpt-ad-1528181032761-2').setTargeting('forum', ['3513']).setTargeting('topic', ['489756']).addService(googletag.pubads()); googletag.defineSlot('\/1010898\/sgforums_supersky', [ 160.0 , 600.0], 'div-gpt-ad-1528181032761-3').setTargeting('forum', ['3513']).setTargeting('topic', ['489756']).addService(googletag.pubads()); googletag.pubads().enableSingleRequest(); googletag.enableServices();});</script>
  </head>
  <body>
    <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-PK63DK"height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
    <div class='container'>
      <a href='/'>Home</a>
      >
      <a href='/forums/3513/'>PR Newswire Asia</a>
      <h1>NMT Pharmaceuticals Singapore Announces Signing of Letter...</h1>
      <nav class='pagination'>
      </nav>
      <ul class='list-group posts'>
        <li class='list-group-item post'>
          <div class='row'>
            <div class='col-md-2 meta'>
              <div class='author'>Helen.zhang</div>
              <time class='date' datetime='2015-08-25T11:36:02+00:00'>25 Aug 15, 11:36</time>
            </div>
            <div class='col-md body'>
              <div id="dvContent" style="font-size: 12px; line-height: 1.6em; color: #464646; word-wrap: break-word; font-family: Arial, Helvetica, sans-serif;">
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"><span class="xn-location" style="font-family: Arial, 'Times New Roman', Times, serif;">SINGAPORE </span>/PRNewswire/ -- NMT Pharmaceuticals Pte Ltd (NMT Pharma<span id="spanHghlt0732" style="font-family: Arial, 'Times New Roman', Times, serif;">) a</span>nnounced today that it has signed a legally binding Letter of Intent with US-based CAO <span id="spanHghlt95c8" style="font-family: Arial, 'Times New Roman', Times, serif;">Pharmacueticals</span> Inc. (CAO Pharma) for acquiring an exclusive worldwide license right to further develop and market an anti-cancer drug CZ-48 co-developed by CAO Pharma and NMT Pharma.</p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">NMT Pharma and CAO Pharma will enter into agreements that would secure funding needed by CAO Pharma to continue to operate and conduct clinical trials in <span id="spanHghlt631c" style="font-family: Arial, 'Times New Roman', Times, serif;">the</span> US. The collaboration is subjected to, among with other requirements, satisfactory completion of due diligence and the execution of a definitive agreement.</p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">CZ-48 is an analogue of camptothecin which is stable and resistant to inactivation while circulating in human bloodstream. This topoisomerase I inhibitor only becomes active when entering in tumor cells. Based on preclinical and previous Phase I clinical trial data, CZ-48 has very low toxicity and mild side effects. CAO Pharma and NMT Pharma have improved the formulation of CZ-48 to increase the bioavailability of the drug so as to further reduce the side effects and improve therapeutic effects. CAO Pharma intends to re-start the Phase I clinical study program with the new CZ-48 formulation within this year.</p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"><strong><em>About NMT Pharmaceuticals Pte Ltd (</em></strong><a style="margin: 0px; color: #6099e9; outline: none;" rel="nofollow" href="http://www.nanomt.com/"><strong><em>http://www.nanomt.com</em></strong></a><strong><em>)</em></strong></p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"> </p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"><em>NMT Pharmaceuticals Pte Ltd is a <span class="xn-location" style="font-family: Arial, 'Times New Roman', Times, serif;">Singapore</span> and spin off company from the pharmaceutical business division of NanoMaterials Technology Pte Ltd (NMT). As a wholly-owned subsidiary company of NMT, it has a proprietary technology called High Gravity Controlled Precipitation (HGC</em><em>P) Technology and other </em><em>patented dispersion technology to improve the bioavailability of micro- and nano-drug particles and formulations.</em></p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"> </p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"> </p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"> </p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"><strong><em>About CAO <span id="spanHghltc188" style="font-family: Arial, 'Times New Roman', Times, serif;">Pharmacueticals </span>Inc.</em></strong></p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"><em>CAO <span id="spanHghltb83a" style="font-family: Arial, 'Times New Roman', Times, serif;">Pharmacueticals</span> Inc. is a start-up company based in <span class="xn-location" style="font-family: Arial, 'Times New Roman', Times, serif;">Houston, Texas</span> with its business focusing on discovery, development, manufacturing and selling of anti-cancer drugs. The company<span id="spanHghlt4ed6" style="font-family: Arial, 'Times New Roman', Times, serif;">'s</span> leading drug is CZ-48 which has </em><em>a broad spectrum of anti-cancer activity against various types of human tumors, such a<span id="spanHghlta665" style="font-family: Arial, 'Times New Roman', Times, serif;">s p</span>ancreatic, breast, lung, ovarian, bladder, colon, kidney, liver, stomach, lymph, and head and neck cancers, as well as melanomas. New drug pipelines are being developed and in preparation for IND filling to FDA. </em><em>The company's management team is led by <span class="xn-person" style="font-family: Arial, 'Times New Roman', Times, serif;">Zhisong Cao</span>, PhD., who has more than 20 years of experience in developing anti-cancer drugs. His team has vast experience and knowledge in conducting clinical trials in Phase I and II.</em></p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"> </p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;">Media Contact Details:</p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"><strong>NMT Pharmaceuticals Pte Ltd <br></strong>Tel: +65-6270-0733 <br>Mr. <span class="xn-person" style="font-family: Arial, 'Times New Roman', Times, serif;">David Sher</span>, <a style="margin: 0px; color: #6099e9; outline: none;" rel="nofollow" href="mailto:david.sher@nanomt.com">david.sher@nanomt.com</a></p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"> </p>
              <p style="margin-top: 10px; margin-bottom: 10px; line-height: 1.6em;"><strong>CAO <span id="spanHghlt1298" style="font-family: Arial, 'Times New Roman', Times, serif;">Pharmacueticals</span> Inc. <br></strong>Tel: +1-832-626-2052 <br>Dr. <span class="xn-person" style="font-family: Arial, 'Times New Roman', Times, serif;">Zhisong Cao</span>, <a style="margin: 0px; color: #6099e9; outline: none;" rel="nofollow" href="mailto:zhisongc@caopharmaceuticals.com"><span id="spanHghlt0c33" style="font-family: Arial, 'Times New Roman', Times, serif;">zhisongc@caopharmaceuticals.com</span></a></p>
              </div>
              <div id="dvSource" style="font-size: 12px; margin-top: 25px; margin-bottom: 5px; color: #666666; font-family: Arial, Simsun, Helvetica, sans-serif; line-height: 12px;">Source: NMT Pharmaceuticals Pte Ltd</div>
              <div class="dvWebsites" style="line-height: 1.5em; margin-top: 15px; color: #464646; font-family: Arial, Simsun, Helvetica, sans-serif; font-size: 12px;">Related Links:
              <ul style="margin: 0px; list-style: none;">
              <li><a style="margin: 0px; color: #6099e9; outline: none;" rel="nofollow" href="http://www.nanomt.com/">http://www.nanomt.com</a></li>
              <li><a style="margin: 0px; color: #6099e9; outline: none;" rel="nofollow" href="http://www.caopharmaceuticals.com/">http://www.caopharmaceuticals.com</a></li>
              </ul>
              </div>
            </div>
          </div>
        </li>
        <li class='list-group-item'>
          <div id='div-gpt-ad-1528181032761-2' style='height:250px; width:300px;'><script>googletag.cmd.push(function(){googletag.display('div-gpt-ad-1528181032761-2');});</script></div>
        </li>
      </ul>
      <nav class='pagination'>
      </nav>
      <footer>
        <nav class='nav'>
          <a class='nav-link' href='/'>Home</a>
          <a class='nav-link' href='/privacy/'>Privacy</a>
          <a class='nav-link' href='/terms/'>Terms</a>
        </nav>
      </footer>
    </div>
    <div id='div-gpt-ad-1528181032761-0' style='height:1px; width:1px;'><script>googletag.cmd.push(function(){googletag.display('div-gpt-ad-1528181032761-0');});</script></div>
  </body>
</html>
